To determine whether C4 CAR-modified human T cells were able to recognize αFRpos tumor cells, the C4-27z CAR-bearing T cells were cultured with tumor cells, and IFN-γ and IL-2 responses measured by ELISA. This evidence concerns the gene IFNG and neoplasm.